Skip links
Companies
Greece › BIOMINERALES PHARMA EUROPE P.C.

BIOMINERALES PHARMA EUROPE P.C.

Active

Registration No.
165479603000
Incorporation Date
2022-09-02
Company Type
N/A
Address
PAIANIA, Greece
Website
www.deltabang.eu/
Source: General Commercial Registry (GEMI)

BIOMINERALES PHARMA EUROPE P.C. is a registered legal entity registered in Greece under 165479603000, and its current status with General Commercial Registry (GEMI) is active. The company was incorporated on 2 September 2022 and lists its registered address as PAIANIA, Greece. 3 shareholders are on record for BIOMINERALES PHARMA EUROPE P.C., including at least one natural person recorded as a direct holder; the filing carries no beneficial-ownership flag, so that holder is noted here as a recorded shareholder rather than a confirmed ultimate beneficial owner (UBO). This profile is sourced directly from General Commercial Registry (GEMI) and was last updated on 14 August 2026.

Data Provenance
This record is sourced directly from official government registries, including General Commercial Registry (GEMI).

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

3

Three shareholders are currently on record for BIOMINERALES PHARMA EUROPE P.C., filed with General Commercial Registry (GEMI).

The largest of these is SAMAKOVLIS MANAGEMENTS MONOPROSOPI IKE, holding 33.3% — the largest recorded stake — followed by SAMAKOVLIS MANAGEMENT MONOPROSOPI IKE at 33.3%; the remaining 1 shareholder shown holds smaller stakes.

2 shareholders shown are companies, so the ownership chain continues above this level for those holdings; the other 1 is recorded as direct individual holder, though the record carries no UBO/PSC flag confirming beneficial-owner status.

Shareholder Type Holding Source Document
SAMAKOVLIS MANAGEMENTS MONOPROSOPI IKE 33.3% General Commercial Registry (GEMI)
SAMAKOVLIS MANAGEMENT MONOPROSOPI IKE 33.3% General Commercial Registry (GEMI)
ADRIANA SHAW 33.3% General Commercial Registry (GEMI)

View all shareholders & beneficial ownership
Full cap table, ownership percentages, and ultimate beneficial owners resolved down to the natural person.

View all shareholders →

Officers

4

Four officers are currently on record for BIOMINERALES PHARMA EUROPE P.C., filed with General Commercial Registry (GEMI). Georgios Samakovlis serves as Administrator, appointed 2022-09-02; Samakovlis Managements Monoprosopi Ike, Adriana Shaw and Samakovlis Management Monoprosopi Ike all serve as Partner – Member, appointed 2023-07-11 and 2023-07-11 and 2025-01-29.

Management authority at BIOMINERALES PHARMA EUROPE P.C. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

GS
Georgios Samakovlis RESIGNED

Appointed
2022-09-02
Resigned
9999-12-31
Residence
🇬🇷 Greece
Occupation
Administrator

SM
Samakovlis Managements Monoprosopi Ike ACTIVE

Appointed
2023-07-11
Residence
🇬🇷 Greece
Occupation
Partner – Member

AS
Adriana Shaw ACTIVE

Appointed
2023-07-11
Residence
🇬🇷 Greece
Occupation
Partner – Member

SM
Samakovlis Management Monoprosopi Ike ACTIVE

Appointed
2025-01-29
Residence
🇬🇷 Greece
Occupation
Partner – Member

View all officers & directors
Complete appointment history, representation authority, and officer-level filings across jurisdictions.

View all officers →

Group Structure

BIOMINERALES PHARMA EUROPE P.C. sits 1 level below its ultimate parent, SAMAKOVLIS MANAGEMENT P.C., registered in Greece. The full chain up to SAMAKOVLIS MANAGEMENT P.C. is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by BIOMINERALES PHARMA EUROPE P.C.'s own shareholder record.

Ultimate HQ
SAMAKOVLIS MANAGEMENT P.C.
Greece

Explore the full group structure
Map the complete corporate hierarchy: parent companies, subsidiaries, and cross-border ownership chains.

View full group structure →

Need the full UBO picture on BIOMINERALES PHARMA EUROPE P.C.?

Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.

Frequently Asked Questions

Who owns BIOMINERALES PHARMA EUROPE P.C.?

Three shareholders are currently on record for BIOMINERALES PHARMA EUROPE P.C., filed with General Commercial Registry (GEMI). The largest of these is SAMAKOVLIS MANAGEMENTS MONOPROSOPI IKE, holding 33.3% — the largest recorded stake — followed by SAMAKOVLIS MANAGEMENT MONOPROSOPI IKE at 33.3%; the remaining 1 shareholder shown holds smaller stakes. 2 shareholders shown are companies, so the ownership chain continues above this level for those holdings; the other 1 is recorded as direct individual holder, though the record carries no UBO/PSC flag confirming beneficial-owner status.

Who is BIOMINERALES PHARMA EUROPE P.C.'s UBO (Ultimate Beneficial Owner)?

At least one shareholder recorded for BIOMINERALES PHARMA EUROPE P.C. is a natural person. The record carries no dedicated UBO/PSC flag, so that holder is stated here as a recorded shareholder rather than a confirmed Ultimate Beneficial Owner (UBO).

How many shareholders does BIOMINERALES PHARMA EUROPE P.C. have on record?

3 shareholders are shown on record for BIOMINERALES PHARMA EUROPE P.C..

What is BIOMINERALES PHARMA EUROPE P.C.'s company registration number?

BIOMINERALES PHARMA EUROPE P.C.'s registration number is 165479603000, filed with General Commercial Registry (GEMI) in Greece. Its current status on the register is active.

Is BIOMINERALES PHARMA EUROPE P.C. still an active company?

BIOMINERALES PHARMA EUROPE P.C.'s status on General Commercial Registry (GEMI) is listed as active.

When was BIOMINERALES PHARMA EUROPE P.C. incorporated?

BIOMINERALES PHARMA EUROPE P.C. was incorporated on 2 September 2022, according to General Commercial Registry (GEMI).

What is BIOMINERALES PHARMA EUROPE P.C.'s registered address?

The registered address on file for BIOMINERALES PHARMA EUROPE P.C. is PAIANIA, Greece.

Who are the officers/directors of BIOMINERALES PHARMA EUROPE P.C.?

Four officers are currently on record for BIOMINERALES PHARMA EUROPE P.C., filed with General Commercial Registry (GEMI). Georgios Samakovlis serves as Administrator, appointed 2022-09-02; Samakovlis Managements Monoprosopi Ike, Adriana Shaw and Samakovlis Management Monoprosopi Ike all serve as Partner – Member, appointed 2023-07-11 and 2023-07-11 and 2025-01-29. Management authority at BIOMINERALES PHARMA EUROPE P.C. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Does BIOMINERALES PHARMA EUROPE P.C. have a parent company or subsidiaries?

BIOMINERALES PHARMA EUROPE P.C. sits 1 level below its ultimate parent, SAMAKOVLIS MANAGEMENT P.C., registered in Greece.

Can Zavia monitor changes to BIOMINERALES PHARMA EUROPE P.C.'s ownership over time?

This profile reflects a point-in-time snapshot from General Commercial Registry (GEMI). Zavia's monitoring API can track changes to BIOMINERALES PHARMA EUROPE P.C.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.

Can I access BIOMINERALES PHARMA EUROPE P.C.'s data through an API?

Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Greece, so records like BIOMINERALES PHARMA EUROPE P.C.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.

Where does this company information come from, and how current is it?

This record is sourced directly from General Commercial Registry (GEMI) and was last synced on 14 August 2026.

This website uses cookies to improve your web experience.